Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma

Fig. 4

LYRM4 is a poor prognostic factor for LIHC progression and patient survival (GEPIA2 database). a Kaplan-Meier overall survival (OS) curve of LIHC patients (n = 364) based on LYRM4 mRNA expression level. b Kaplan-Meier disease free survival analysis was performed on LIHC patients according to the expression level of LYRM4

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us